Loss of CD96 Expression as a Marker of HIV-Specific CD8+ T-Cell Differentiation and Dysfunction

  • Rémi Bunet
  • , Manon Nayrac
  • , Hardik Ramani
  • , Mohamed Sylla
  • , Madeleine Durand
  • , Carl Chartrand-Lefebvre
  • , Jean Pierre Routy
  • , Alan L. Landay
  • , Jean Francois Gauchat
  • , Nicolas Chomont
  • , Petronela Ancuta
  • , Daniel E. Kaufmann
  • , Nicole Bernard
  • , Cécile L. Tremblay
  • , Mohamed El-Far

Research output: Contribution to journalArticlepeer-review

Abstract

Persistent immune activation and inflammation in people living with HIV (PLWH) are associated with immunosenescence, premature aging and increased risk of non-AIDS comorbidities, with the underlying mechanisms not fully understood. In this study, we show that downregulation of the T-cell immunoglobulin receptor CD96 on CD8+ T cells from PLWH is associated with decreased expression of the co-stimulatory receptors CD27 and CD28, higher expression of the senescence marker CD57 and accumulation of a terminally differentiated T-cell memory phenotype. In addition, we show that CD96-low CD8+ T-cells display lower proliferative potential compared to their CD96-high counterparts and that loss of CD96 expression by HIV-specific CD8+ T-cells is associated with a suboptimal response to HIV antigens. In conclusion, our results suggest that CD96 marks CD8+ T-cells with competent responses to HIV and the loss of its expression might be used as a biomarker for CD8+ T-cell senescence and dysfunction in PLWH.

Original languageEnglish (US)
Article number673061
JournalFrontiers in immunology
Volume12
DOIs
StatePublished - May 27 2021
Externally publishedYes

Keywords

  • CD96
  • HIV
  • T-cell dysfunction, IL-32
  • T-cell senescence
  • people living with HIV (PLWH)

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Loss of CD96 Expression as a Marker of HIV-Specific CD8+ T-Cell Differentiation and Dysfunction'. Together they form a unique fingerprint.

Cite this